tiprankstipranks
Trending News
More News >
Kindstar Globalgene Technology, Inc. (HK:9960)
:9960
Hong Kong Market

Kindstar Globalgene Technology, Inc. (9960) Price & Analysis

Compare
0 Followers

9960 Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.82%99.18%
Insiders
0.82%
Mutual Funds
― Other Institutional Investors
99.18% Public Companies and
Individual Investors

9960 FAQ

What was Kindstar Globalgene Technology, Inc.’s price range in the past 12 months?
Kindstar Globalgene Technology, Inc. lowest stock price was HK$0.93 and its highest was HK$1.50 in the past 12 months.
    What is Kindstar Globalgene Technology, Inc.’s market cap?
    Kindstar Globalgene Technology, Inc.’s market cap is HK$1.43B.
      When is Kindstar Globalgene Technology, Inc.’s upcoming earnings report date?
      Kindstar Globalgene Technology, Inc.’s upcoming earnings report date is Sep 02, 2025 which is in 56 days.
        How were Kindstar Globalgene Technology, Inc.’s earnings last quarter?
        Kindstar Globalgene Technology, Inc. released its earnings results on Mar 28, 2025. The company reported -HK$0.078 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.078.
          Is Kindstar Globalgene Technology, Inc. overvalued?
          According to Wall Street analysts Kindstar Globalgene Technology, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Kindstar Globalgene Technology, Inc. pay dividends?
            Kindstar Globalgene Technology, Inc. pays a Annually dividend of HK$0.023 which represents an annual dividend yield of 1.76%. See more information on Kindstar Globalgene Technology, Inc. dividends here
              What is Kindstar Globalgene Technology, Inc.’s EPS estimate?
              Kindstar Globalgene Technology, Inc.’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Kindstar Globalgene Technology, Inc. have?
              Kindstar Globalgene Technology, Inc. has 1,040,758,400 shares outstanding.
                What happened to Kindstar Globalgene Technology, Inc.’s price movement after its last earnings report?
                Kindstar Globalgene Technology, Inc. reported an EPS of -HK$0.078 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.92%.
                  Which hedge fund is a major shareholder of Kindstar Globalgene Technology, Inc.?
                  Currently, no hedge funds are holding shares in HK:9960

                  Kindstar Globalgene Technology, Inc. Stock Smart Score

                  5
                  Neutral
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Positive
                  20 days / 200 days
                  Momentum
                  -3.72%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  -1.93%
                  Trailing 12-Months
                  Asset Growth
                  -0.56%
                  Trailing 12-Months

                  Company Description

                  Kindstar Globalgene Technology, Inc.

                  Kindstar Global (Beijing) Technology, Inc. provides medical esoteric testing services to hospitals in China. Its services include medical research, drug trial, and translational medicine research services for physicians, medical science and technology institutions, specialty and general hospitals, and pharmaceutical companies. The company's lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research laboratories. It provides tests in blood, tumor, and genetics; and cardiovascular, cerebrovascular, infectious, and autoimmune diseases, as well as in internal medicine, surgery, gynecology, pediatrics, and other specialties. The company was founded in 2003 and is headquartered in in Wuhan, China.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  New Century Healthcare Holding Co. Ltd.
                  Rici Healthcare Holdings Ltd.
                  Guangdong Kanghua Healthcare Co., Ltd. Class H
                  Hospital Corporation of China Ltd
                  Town Health International Medical Group Ltd.
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis